Our previous study reported that JWA (adenosine diphophate-ribosylation-like factor 6 interacting protein 5, ARL6ip5) reversed cisplatin resistance in human GC59, whereas lower expression of JWA sensitized cisplatin-resistant GC cells to lapatinib-induced apoptosis32. Here, ARL6IP5 is linked to gastric cancer.